Rene Russo - 05 Aug 2021 Form 4 Insider Report for Adagio Therapeutics, Inc. (IVVD)

Reporting relationship: Director
Issuer ticker: IVVD
Reported as of: 05 Aug 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Aug 2021, 19:55:19 UTC
Prior SEC filing: 02 Jun 2021
Next SEC filing: 21 Oct 2021
Source filing: View source filing
Reporting owner signature: /s/ Dorothy Vinsky, Attorney-in-Fact

Key filing fact

Rene Russo filed Form 4 for Adagio Therapeutics, Inc. (IVVD) on 09 Aug 2021.

Key facts

This page summarizes Rene Russo's Form 4 filing for Adagio Therapeutics, Inc. (IVVD).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 09 Aug 2021, 19:55.

Change

Previous filing in this sequence was filed on 02 Jun 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IVVD transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +35,593
Change %
Price: $0.000000
Shares after: 35,593
Date: 05 Aug 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 35,593
Exercise price: $17.00
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

One third (1/3) of the option shall vest on August 5, 2022, and thereafter, the remainder of the option shall vest in 24 equal monthly installments on the 5th day of each month, subject to the Reporting Person's continuous service on each vesting date.